Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serological changes in progressive systemic sclerosis.

P Davis, M I Jayson

    Rheumatology and Rehabilitation
    |February 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mechanisms of chronicity?

    Journal of back and musculoskeletal rehabilitation·2014
    Same author

    Debate: This Society believes that in the last 25 years of back pain research we have failed to see the wood for the trees - Chaired by C.G. Greenough.

    Journal of back and musculoskeletal rehabilitation·2014
    Same author

    Gender variation of human spinal and paraspinal structures.

    Clinical biomechanics (Bristol, Avon)·2013
    Same author

    Fenclofenac tolerance in the dyspeptic patient.

    Proceedings of the Royal Society of Medicine·2010
    Same author

    Selective changes in multifidus dimensions in patients with chronic low back pain.

    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2010
    Same author

    Endothelial-dependent vasodilation is impaired in patients with systemic sclerosis, as assessed by low dose iontophoresis.

    Clinical and experimental rheumatology·2003
    Same journal

    Parenteral iron therapy in the anaemia of rheumatoid arthritis.

    Rheumatology and rehabilitation·1982
    Same journal

    Diclofenac sodium, diflunisal and naproxen: patient preferences for anti-inflammatory drugs in rheumatoid arthritis.

    Rheumatology and rehabilitation·1982
    Same journal

    Polymyalgia rheumatica in a defined elderly community.

    Rheumatology and rehabilitation·1982
    Same journal

    The recovery of the severely disable stroke patient.

    Rheumatology and rehabilitation·1982
    Same journal

    Multisystem presentation of eosinophilic fasciitis.

    Rheumatology and rehabilitation·1982
    Same journal

    Group G streptococcal arthritis.

    Rheumatology and rehabilitation·1982
    See all related articles

    Auto-antibodies were investigated in scleroderma patients. While some antibodies were present, they were mainly linked to progressive systemic sclerosis, not disease severity or other autoimmune conditions.

    Area of Science:

    • Immunology
    • Rheumatology
    • Autoimmune Diseases

    Background:

    • Scleroderma is a complex autoimmune condition characterized by hardening of the skin and connective tissues.
    • The presence and significance of auto-antibodies in scleroderma pathogenesis and clinical presentation require further elucidation.

    Purpose of the Study:

    • To investigate the spectrum of auto-antibodies in patients diagnosed with scleroderma.
    • To determine the association of these auto-antibodies with disease subtype, severity, and clinical manifestations.

    Main Methods:

    • Serum samples from 37 scleroderma patients were analyzed for auto-antibodies.
    • Specific assays were employed to detect rheumatoid factors, antibodies to smooth muscle, thyroid, nuclear antigens, and double-stranded DNA.

    Related Experiment Videos

    Main Results:

    • Rheumatoid factors and antibodies to smooth muscle and thyroid were detected in some patients.
    • Antibodies to nuclear antigens (ANA) were found in 32% of patients, not correlating with disease extent or severity.
    • Serological changes were predominantly observed in progressive systemic sclerosis, but not in morphoea.
    • Antibodies to double-stranded DNA were rare, and no significant overlap with systemic lupus erythematosus was noted.

    Conclusions:

    • Auto-antibody profiles in scleroderma patients vary, with ANA being a notable finding in progressive systemic sclerosis.
    • The presence of specific auto-antibodies may not directly correlate with disease severity but can be associated with complications or other co-existing diseases.
    • These findings help differentiate scleroderma subtypes and inform diagnostic and prognostic considerations.